Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023

SELL
$8.75 - $14.02 $1.6 Million - $2.56 Million
-182,628 Reduced 86.5%
28,501 $395,000
Q1 2022

May 11, 2022

SELL
$23.26 - $42.41 $2,674 - $4,877
-115 Reduced 0.05%
211,129 $6.16 Million
Q4 2021

Feb 10, 2022

BUY
$37.54 - $57.51 $51,354 - $78,673
1,368 Added 0.65%
211,244 $8.93 Million
Q2 2021

Aug 10, 2021

BUY
$43.3 - $67.17 $8.36 Million - $13 Million
193,026 Added 1145.55%
209,876 $12.3 Million
Q1 2021

May 14, 2021

BUY
$44.11 - $90.64 $743,253 - $1.53 Million
16,850 New
16,850 $985,000

Others Institutions Holding QTRX

About Quanterix Corp


  • Ticker QTRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,987,600
  • Market Cap $426M
  • Description
  • Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...
More about QTRX
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.